89BIO_AASLD_2022
Loading viewer...
report
Format: PDF report
This report presents findings from a Phase 1b/2a study on Pegozafermin for treating Non-Alcoholic Steatohepatitis (NASH), highlighting key results and implications.
Loading viewer...
report
Format: PDF report
This report presents findings from a Phase 1b/2a study on Pegozafermin for treating Non-Alcoholic Steatohepatitis (NASH), highlighting key results and implications.
presentation
report
Frasers Group
report
888 Holdings plc
report
TD Bank
report
VGI Partners
